Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 1998

View Archived Issues

Biogen: Q4 and FY 1997 highlights

Lilly and Allelix expand research programs

Chesapeake Biological Laboratories and LXR to codevelop Cardiosol products

New approach to cancer therapy reported

Lilly researchers prepare novel 5-HT reuptake inhibitors

Resistance modulators for use in cancer and malaria developed at Lilly

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Antifungal antibiotics isolated by Takara Shuzo

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Takeda discloses compounds that upregulate LDL receptors

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

U.K. launch for Posicor

Wyeth-Ayerst licenses PEPCK-modulating compounds

New antimigraine combination addresses both headache and vomiting

Progenitor and Affymetrix collaborate on asthma research

New bacterial genomics company established by Theratechnologies

First pivotal trial of lisofylline completed

Mentor obtains marketing rights to new cancer therapeutic from Intracel

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

AtheroGenics initiates phase I testing for new cardiovascular drug

Vion prepares more active prodrug of beta-L-FD4C

Phytochemistry alliance formed by Xenova Discovery and IGER

AltaRex reacquires Western European marketing rights to Ovarex

Once-daily hair loss treatment available throughout the U.S.

RTX enters phase II for urge incontinence

New once-daily rosacea therapy introduced in U.S.

Common variant of CETP gene correlated with atherosclerosis progression, response to pravastatin

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...